Oklahoma 2026 Regular Session

Oklahoma Senate Bill SB771

Introduced
2/3/25  

Caption

Advertising; prohibiting certain direct-to-consumer advertising by pharmaceutical companies; creating felony offense. Effective date. Emergency.

Impact

If enacted, SB771 would significantly alter existing regulations surrounding pharmaceutical marketing in Oklahoma. By banning DTC advertising, the bill intends to improve the integrity of doctor-patient relationships and promote informed decision-making. It aims to align Oklahoma with global standards, as most other countries do not allow DTC pharmaceutical advertising. This shift would remove a significant marketing avenue for pharmaceutical companies operating in the state, which some argue is crucial for consumer awareness regarding available medications.

Summary

Senate Bill 771 aims to prohibit direct-to-consumer (DTC) advertising of pharmaceutical products in Oklahoma. The bill finds that DTC advertising can exploit public understanding of medical science, potentially misleading consumers and influencing healthcare provider prescribing practices. The legislation cites previous cases of misleading advertisements contributing to public health crises, notably the opioid epidemic linked to aggressive advertising of drugs like OxyContin and Vioxx. Additionally, the bill emphasizes the financial burden that the cost of advertising places on consumers and the healthcare system, thereby advocating for a more responsible marketing approach in the pharmaceutical industry.

Contention

The bill faces potential contention regarding its implications on pharmaceutical company marketing strategies. Proponents argue that the prohibition is essential for public health and will prevent over-medicalization and misinformed use of medications. Opponents may argue that banning such advertisements limits consumer knowledge and access to information about available treatments, possibly infringing on the companies' rights to market their products. There are also concerns about how this will impact smaller pharmaceutical entities that rely more heavily on DTC advertising to reach consumers.

Companion Bills

OK SB771

Carry Over Advertising; prohibiting certain direct-to-consumer advertising by pharmaceutical companies; creating felony offense. Effective date. Emergency.

Previously Filed As

OK SB771

Advertising; prohibiting certain direct-to-consumer advertising by pharmaceutical companies; creating felony offense. Effective date. Emergency.

OK SB1001

Corporation Commission; prohibiting certain public utilities from taking certain actions relating to advertising. Effective date.

OK SB191

Medical marijuana; expanding certain restrictions on certain advertising. Effective date.

OK SB984

Highway Advertising Control Act of 1972; defining term. Effective date.

OK HB2053

Transportation; outdoor advertising; defining term; effective date.

OK SB801

Pharmaceutical companies; creating the Oklahoma Medicine Injury Justice Act; providing for civil and criminal liability. Effective date. Emergency.

OK HB2104

Classification of felony offenses; designating classification for certain offenses; effective date.

OK SB780

Flag-related offenses; creating felony offense and providing penalties. Effective date.

OK HB1191

Agriculture; donkey milk advertising; Oklahoma Milk and Milk Products Act; donkey milk; effective date.

OK SB945

Crimes and punishments; relating to animal cruelty; creating misdemeanor and felony offenses; modifying scope and penalty of certain felony offense. Effective date.

Similar Bills

CA AB2717

Outdoor advertising displays: arenas: exemptions.

CA SB1050

False advertising: synthetic digital performers.

HI SB2733

Relating To Liquor.

CA AB840

Outdoor advertising displays: redevelopment agency project areas.

CA SB783

Outdoor advertising displays: redevelopment agency project areas.

CA AB770

Advertising displays: City of Los Angeles: exemption: ordinance.

AZ HB2179

Marijuana; advertising; restrictions

CA SB1228

Advertising displays: exemptions: redevelopment agency projects.